C-Rad AB (OSTO:CRAD B) FCF Margin % : 21.63% (As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is C-Rad AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. C-Rad AB's Free Cash Flow for the three months ended in Mar. 2025 was kr25.7 Mil. C-Rad AB's Revenue for the three months ended in Mar. 2025 was kr118.8 Mil. Therefore, C-Rad AB's FCF Margin % for the quarter that ended in Mar. 2025 was 21.63%.

As of today, C-Rad AB's current FCF Yield % is 3.33%.

The historical rank and industry rank for C-Rad AB's FCF Margin % or its related term are showing as below:

OSTO:CRAD B' s FCF Margin % Range Over the Past 10 Years
Min: -58.83 Med: 0.98 Max: 8.28
Current: 8.28

During the past 13 years, the highest FCF Margin % of C-Rad AB was 8.28%. The lowest was -58.83%. And the median was 0.98%.

OSTO:CRAD B's FCF Margin % is ranked better than
72.18% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: -2.64 vs OSTO:CRAD B: 8.28

C-Rad AB FCF Margin % Historical Data

The historical data trend for C-Rad AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB FCF Margin % Chart

C-Rad AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

5.26

4.74

-0.51

3.87

4.99

C-Rad AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
FCF Margin %	Get a 7-Day Free Trial															13.98	-2.01	-17.18	27.16	21.63

Competitive Comparison of C-Rad AB's FCF Margin %

For the Medical Devices subindustry, C-Rad AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

C-Rad AB's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where C-Rad AB's FCF Margin % falls into.

Save Embed

;

Save Embed

;

C-Rad AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

C-Rad AB's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	23.409	/	469.004
	=	4.99 %

C-Rad AB's FCF Margin for the quarter that ended in Mar. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2025 )	/	Revenue (Q: Mar. 2025 )
	=	25.7	/	118.8
	=	21.63 %

C-Rad AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of C-Rad AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

C-Rad AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (OSTO:CRAD B) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

0R44:UK 24C:Germany

Address

Sjukhusvagen 12K, Uppsala, SWE, 753 09

Website

https://www.c-rad.com

C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.

C-Rad AB Headlines

No Headlines